OOIR: Observatory of International Research

Papers

(The H4-Index of JACC: Cardiooncology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Full Issue PDF	135
Priorities in Cardio-Oncology	132
Balancing Promise and Evidence	115
Hormonal Therapy and Cardiovascular Health	102
Full Issue PDF	94
Epigenomics of Cardio-Oncology	81
LAG3 Blockade Expands T Cells Within Atherosclerotic Plaque	76
Atrial Fibrillation in Patients With Cancer	76
Full Issue PDF	72
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy	66
Editorial Board	65
Cardiovascular Safety in Oncology Clinical Trials	61
Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients	61
Behaviorally Designed Gamification and Physical Activity Among Breast and Prostate Cancer Survivors	60
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy	59
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes	56
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part	56
Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors	55
Full Issue PDF	51
Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD	51
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms	48
Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis	45
CARDIAC, MUSCULAR, AND NEUROLOGICAL TOXICITY SECONDARY TO PEMBROLIZUMAB IN A PATIENT WITH MELANOMA	42
Frailty	42
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy	41

Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients	40
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma	39
Cardiac Risk Stratification Before Lung Cancer Radiation	39
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)	36
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy	36
Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis	33
Editorial Board/Officers Page	33
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD	33